Note: Ingredients listed on restricted chemical lists
EC/CAS
288-32-4
Name of the chemical
Imidazol (2015/1221)
Concentration
N/A
General Information
Revision date
2020-07-30
Product name
Chromo LAL
CAS No.
288-32-4
supplier name
MJS BioLynx
Icons in SDS
Company Information
company name
Associates of Cape Cod, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
cherinm@biolynx.ca
GHS Information
Signal word
Danger
Section 2
2.1 Classification of the substance or mixture
Acute toxicity - Oral Category 4 Skin corrosion/irritation Category 1 Sub-category C Serious eye damage/eye irritation Category 1 Reproductive toxicity Category 1B
2.2 Label elements
Danger
Hazard statements
Harmful if swallowed Causes severe skin burns and eye damage May damage fertility or the unborn child
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves/protective clothing/eye protection/face protection. Wash face, hands and any exposed skin thoroughly after handling. Do not eat, drink or smoke when using this product. Do not breathe dusts or mists.
Response
Immediately call a POISON CENTER or doctor. Specific treatment (see supplemental first aid instructions on this label). Eyes IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Skin IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/ shower. Wash contaminated clothing before reuse. Inhalation IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER or doctor. Ingestion IF SWALLOWED: Call a POISON CENTER or doctor if you feel unwell. Rinse mouth. Do NOT induce vomiting.
Storage
Store locked up
Precautionary statements
Disposal Dispose of contents/container to an approved waste disposal plant.
Further information
No information available. Unknown acute toxicity 50 % of the mixture consists of ingredient(s) of unknown acute oral toxicity